feed
view company updates
tools
perform investment research
network
join events & discussions
advisory
about us
Redeye Capital
Pila Pharma: Rights Issue Outcome
Research Note
2022-11-22
14:34
Redeye leaves a short comment on Pila Pharma following the outcome of its rights issue which raised SEK6.9m before issuing costs.
FE
Filip Einarsson
Sign up for free to continue
Sign up with Email
Sign in with Google
Already a member?
Sign in
Disclosures and disclaimers
Premium Plan required to unlock
Unlock companies to access
more high quality research.
View Plans